{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:56:07Z","timestamp":1791899767772,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Although protein palmitoylation has been associated with Alzheimer\u2019s Disease (AD), it remains unclear whether or how palmitoylation of specific proteins contributes to any of the pathological features of AD. The p75 neurotrophin receptor (p75\n                    <jats:sup>NTR<\/jats:sup>\n                    ) contributes to AD progression by regulating the intracellular trafficking and amyloidogenic processing of amyloid precursor protein (APP). p75\n                    <jats:sup>NTR<\/jats:sup>\n                    is palmitoylated at a juxtamembrane cysteine but it is currently unknown whether this has any effect on its role in AD. Here, we report that 5xFAD mice, an animal model of AD, expressing a palmitoylation-deficient mutant of p75\n                    <jats:sup>NTR<\/jats:sup>\n                    (p75\n                    <jats:sup>C281A<\/jats:sup>\n                    ) display significantly attenuated neuropathology and cognitive deficits. Mechanistically, p75\n                    <jats:sup>C281A<\/jats:sup>\n                    showed enhanced internalization, trafficking to Rab5\/Rab7 endosomes and lysosomal-mediated degradation. In mutant p75\n                    <jats:sup>C281A<\/jats:sup>\n                    neurons, APP displayed accelerated co-internalization with p75\n                    <jats:sup>NTR<\/jats:sup>\n                    , increased trafficking to late endosomes and lysosome, and enhanced degradation, thereby limiting neuronal A\u03b2 production. Interestingly, the brain of 5xFAD mice shows increased levels of p75\n                    <jats:sup>NTR<\/jats:sup>\n                    palmitoylation. These results indicate that palmitoylation of p75\n                    <jats:sup>NTR<\/jats:sup>\n                    enhances its stability and, indirectly, that of APP by reducing their trafficking to the lysosome, resulting in increased A\u03b2 accumulation and neuropathology in the AD brain. Selective inhibitors of p75\n                    <jats:sup>NTR<\/jats:sup>\n                    palmitoylation may find applications in the treatment of AD.\n                  <\/jats:p>","DOI":"10.1186\/s13195-026-02032-5","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:58:51Z","timestamp":1774619931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Palmitoylation of death receptor p75NTR contributes to Alzheimer\u2019s disease progression by regulating APP trafficking and degradation"],"prefix":"10.1186","volume":"18","author":[{"given":"Yanchen","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos F.","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"2032_CR1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, Strooper BD. The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011;10:698\u2013712. Available from: http:\/\/www.nature.com\/articles\/nrd3505.","journal-title":"Nat Rev Drug Discov"},{"key":"2032_CR2","doi-asserted-by":"crossref","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25\u00a0years. EMBO Mol Med. 2016;8:595\u2013608. Available from: http:\/\/pubmed.gov\/27025652.","DOI":"10.15252\/emmm.201606210"},{"key":"2032_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. \u03b2-Secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286:735\u201341.","journal-title":"Science"},{"key":"2032_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.phrs.2016.06.008","volume":"111","author":"E Cho","year":"2016","unstructured":"Cho E, Park M. Palmitoylation in Alzheimer\u2019s disease and other neurodegenerative diseases. Pharmacol Res. 2016;111:133\u201351.","journal-title":"Pharmacol Res"},{"key":"2032_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-024-00625-2","volume":"29","author":"J Peng","year":"2024","unstructured":"Peng J, Liang D, Zhang Z. Palmitoylation of synaptic proteins: roles in functional regulation and pathogenesis of neurodegenerative diseases. Cell Mol Biol Lett. 2024;29:108.","journal-title":"Cell Mol Biol Lett"},{"key":"2032_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.12688\/f1000research.6464.1","volume":"4","author":"M Blanc","year":"2015","unstructured":"Blanc M, David F, Abrami L, Migliozzi D, Armand F, B\u00fcrgi J, et al. SwissPalm: protein palmitoylation database. F1000Research. 2015;4:261.","journal-title":"F1000Research"},{"key":"2032_CR7","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/jnr.24003","volume":"95","author":"SM Holland","year":"2017","unstructured":"Holland SM, Thomas GM. Roles of palmitoylation in axon growth, degeneration and regeneration. J Neurosci Res. 2017;95:1528\u201339.","journal-title":"J Neurosci Res"},{"key":"2032_CR8","doi-asserted-by":"publisher","first-page":"e2402604121","DOI":"10.1073\/pnas.2402604121","volume":"121","author":"F Natale","year":"2024","unstructured":"Natale F, Spinelli M, Rinaudo M, Gulisano W, Sarrapochiello IN, Aceto G, et al. Inhibition of zDHHC7-driven protein S-palmitoylation prevents cognitive deficits in an experimental model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2024;121:e2402604121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2032_CR9","doi-asserted-by":"crossref","unstructured":"Barker PA, Barbee G, Misko TP, Shooter EM. The low affinity neurotrophin receptor, p75LNTR, is palmitoylated by thioester formation through cysteine 279. J Biol Chem. 1994;269:30645\u201350. Available from: http:\/\/eutils.ncbi.nlm.nih.gov\/entrez\/eutils\/elink.fcgi?dbfrom=pubmed&id=7982984&retmode=ref&cmd=prlinks.","DOI":"10.1016\/S0021-9258(18)43862-8"},{"key":"2032_CR10","doi-asserted-by":"crossref","unstructured":"Underwood CK, Coulson EJ. The p75 neurotrophin receptor. Int J Biochem Cell Biol. 2008;40:1664\u20138. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1357272507002105.","DOI":"10.1016\/j.biocel.2007.06.010"},{"key":"2032_CR11","doi-asserted-by":"crossref","unstructured":"Ib\u00e1\u00f1ez CF, Simi A. p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity. Trends Neurosci. 2012;35:431\u201340. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223612000501.","DOI":"10.1016\/j.tins.2012.03.007"},{"key":"2032_CR12","doi-asserted-by":"crossref","unstructured":"Ernfors P, Lindefors N, Chan-Palay V, Persson H. Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer type. Dementia. 1990;1:138\u201345. Available from: https:\/\/www.karger.com\/Article\/Abstract\/107133.","DOI":"10.1159\/000107133"},{"key":"2032_CR13","doi-asserted-by":"crossref","unstructured":"Mufson EJ, Kordower JH. Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease. Proc Natl Acad Sci USA. 1992;89:569\u201373. Available from: http:\/\/www.pnas.org\/content\/89\/2\/569.long.","DOI":"10.1073\/pnas.89.2.569"},{"key":"2032_CR14","doi-asserted-by":"crossref","unstructured":"Hu X-Y, Zhang H-Y, Qin S, Xu H, Swaab DF, Zhou J-N. Increased p75(NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients. Exp Neurol. 2002;178:104\u201311. Available from: http:\/\/eutils.ncbi.nlm.nih.gov\/entrez\/eutils\/elink.fcgi?dbfrom=pubmed&id=12460612&retmode=ref&cmd=prlinks.","DOI":"10.1006\/exnr.2002.8018"},{"key":"2032_CR15","doi-asserted-by":"crossref","unstructured":"Chakravarthy B, M\u00e9nard M, Ito S, Gaudet C, Dal-Pra I, Armato U, et al. Hippocampal membrane-associated p75NTR levels are increased in Alzheimer\u2019s disease. J Alzheimers Dis. 2012;30:675\u201384. Available from: http:\/\/eutils.ncbi.nlm.nih.gov\/entrez\/eutils\/elink.fcgi?dbfrom=pubmed&id=22451321&retmode=ref&cmd=prlinks.","DOI":"10.3233\/JAD-2012-120115"},{"key":"2032_CR16","doi-asserted-by":"crossref","unstructured":"Chakravarthy B, Gaudet C, M\u00e9nard M, Atkinson T, Brown L, Laferla FM, et al. Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. J Alzheimers Dis. 2010;19:915\u201325. Available from: http:\/\/eutils.ncbi.nlm.nih.gov\/entrez\/eutils\/elink.fcgi?dbfrom=pubmed&id=20157247&retmode=ref&cmd=prlinks.","DOI":"10.3233\/JAD-2010-1288"},{"key":"2032_CR17","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1523\/JNEUROSCI.2733-10.2011","volume":"31","author":"YJ Wang","year":"2011","unstructured":"Wang YJ, Wang X, Lu JJ, Li QX, Gao CY, Liu XH, et al. p75NTR regulates Abeta deposition by increasing Abeta production but inhibiting Abeta aggregation with its extracellular domain. J Neurosci. 2011;31:2292\u2013304.","journal-title":"J Neurosci"},{"key":"2032_CR18","doi-asserted-by":"crossref","unstructured":"Yi C, Goh KY, Wong L, Ramanujan A, Tanaka K, Sajikumar S, et al. Inactive variants of death receptor p75NTR reduce Alzheimer\u2019s neuropathology by interfering with APP internalization. Embo J. 2021;40:e104450. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7809794\/.","DOI":"10.15252\/embj.2021109067"},{"key":"2032_CR19","doi-asserted-by":"crossref","unstructured":"Fombonne J, Rabizadeh S, Banwait S, Mehlen P, Bredesen DE. Selective vulnerability in Alzheimer\u2019s disease: amyloid precursor protein and p75(NTR) interaction. Ann Neurol. 2009;65:294\u2013303. Available from: http:\/\/onlinelibrary.wiley.com.libproxy1.nus.edu.sg\/doi\/10.1002\/ana.21578\/full.","DOI":"10.1002\/ana.21578"},{"key":"2032_CR20","doi-asserted-by":"crossref","unstructured":"Knowles JK, Rajadas J, Nguyen T-VV, Yang T, LeMieux MC, Griend LV, et al. The p75 Neurotrophin Receptor Promotes Amyloid-beta(1\u201342)-Induced Neuritic Dystrophy In Vitro and In Vivo. J Neurosci. 2009;29:10627\u201337. Available from: http:\/\/eutils.ncbi.nlm.nih.gov\/entrez\/eutils\/elink.fcgi?dbfrom=pubmed&id=19710315&retmode=ref&cmd=prlinks.","DOI":"10.1523\/JNEUROSCI.0620-09.2009"},{"key":"2032_CR21","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/s41591-024-02977-w","volume":"30","author":"HRC Shanks","year":"2024","unstructured":"Shanks HRC, Chen K, Reiman EM, Blennow K, Cummings JL, Massa SM, et al. p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nat Med. 2024;30:1761\u201370.","journal-title":"Nat Med"},{"key":"2032_CR22","unstructured":"Underwood CK, Reid K, May LM, Bartlett PF, Coulson EJ. Palmitoylation of the C-terminal fragment of p75(NTR) regulates death signaling and is required for subsequent cleavage by gamma-secretase. Mol Cell Neurosci. 2008;37:346\u201358. Available from: http:\/\/www.sciencedirect.com\/science?_ob=ArticleURL&_udi=B6WNB-4PYP729-2&_user=650310&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000034918&_version=1&_urlVersion=0&_userid=650310&md5=76f020e83e48b03a4bef1ccb5d96d0ae."},{"key":"2032_CR23","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.nbd.2005.06.004","volume":"20","author":"ZK Mirnics","year":"2005","unstructured":"Mirnics ZK, Yan C, Portugal C, Kim T-W, Saragovi HU, Sisodia SS, et al. P75 neurotrophin receptor regulates expression of neural cell adhesion molecule 1. Neurobiol Dis. 2005;20:969\u201385.","journal-title":"Neurobiol Dis"},{"key":"2032_CR24","doi-asserted-by":"crossref","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340. Available from: http:\/\/eutils.ncbi.nlm.nih.gov\/entrez\/eutils\/elink.fcgi?dbfrom=pubmed&id=17021169&retmode=ref&cmd=prlinks.","DOI":"10.1523\/JNEUROSCI.1202-06.2006"},{"key":"2032_CR25","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.apsb.2021.02.019","volume":"11","author":"S Mazumdar","year":"2021","unstructured":"Mazumdar S, Chitkara D, Mittal A. Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers. Acta Pharm Sin B. 2021;11:903\u201324.","journal-title":"Acta Pharm Sin B"},{"key":"2032_CR26","doi-asserted-by":"publisher","first-page":"22050","DOI":"10.1073\/pnas.1016184107","volume":"107","author":"I Levental","year":"2010","unstructured":"Levental I, Lingwood D, Grzybek M, Coskun \u00dc, Simons K. Palmitoylation regulates raft affinity for the majority of integral raft proteins. Proc Natl Acad Sci U S A. 2010;107:22050\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2032_CR27","doi-asserted-by":"publisher","first-page":"8500","DOI":"10.1073\/pnas.1404582111","volume":"111","author":"BB Diaz-Rohrer","year":"2014","unstructured":"Diaz-Rohrer BB, Levental KR, Simons K, Levental I. Membrane raft association is a determinant of plasma membrane localization. Proc Natl Acad Sci. 2014;111:8500\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"2032_CR28","doi-asserted-by":"publisher","first-page":"36707","DOI":"10.1074\/jbc.274.51.36707","volume":"274","author":"C Huang","year":"1999","unstructured":"Huang C, Zhou J, Feng AK, Lynch CC, Klumperman J, DeArmond SJ, et al. Nerve growth factor signaling in caveolae-like domains at the plasma membrane. J Biol Chem. 1999;274:36707\u201314.","journal-title":"J Biol Chem"},{"key":"2032_CR29","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.febslet.2007.03.080","volume":"581","author":"C Gil","year":"2007","unstructured":"Gil C, Cub\u00ed R, Aguilera J. Shedding of the p75NTR neurotrophin receptor is modulated by lipid rafts. FEBS Lett. 2007;581:1851\u20138.","journal-title":"FEBS Lett"},{"key":"2032_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tcb.2006.11.008","volume":"17","author":"BP Head","year":"2007","unstructured":"Head BP, Insel PA. Do caveolins regulate cells by actions outside of caveolae? Trends Cell Biol. 2007;17:51\u20137.","journal-title":"Trends Cell Biol"},{"key":"2032_CR31","doi-asserted-by":"publisher","first-page":"691045","DOI":"10.3389\/fphys.2021.691045","volume":"12","author":"M Rezola","year":"2021","unstructured":"Rezola M, Castellanos A, Gasull X, Comes N. Functional interaction between caveolin 1 and LRRC8-mediated volume-regulated anion channel. Front Physiol. 2021;12:691045.","journal-title":"Front Physiol"},{"key":"2032_CR32","doi-asserted-by":"crossref","unstructured":"Escudero CA, Lazo OM, Galleguillos C, Parraguez JI, Lopez-Verrilli MA, Cabeza C, et al. The p75 neurotrophin receptor evades the endolysosomal route in neuronal cells, favouring multivesicular bodies specialised for exosomal release. J Cell Sci. 2014;127:1966\u201379. Available from: http:\/\/jcs.biologists.org\/cgi\/doi\/10.1242\/jcs.141754.","DOI":"10.1242\/jcs.141754"},{"key":"2032_CR33","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2147\/IJN.S226186","volume":"15","author":"C-G Liu","year":"2020","unstructured":"Liu C-G, Han Y-H, Kankala RK, Wang S-B, Chen A-Z. Subcellular performance of nanoparticles in cancer therapy. Int J Nanomed. 2020;15:675\u2013704.","journal-title":"Int J Nanomed"},{"key":"2032_CR34","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1523\/JNEUROSCI.23-08-03209.2003","volume":"23","author":"FC Bronfman","year":"2003","unstructured":"Bronfman FC, Tcherpakov M, Jovin TM, Fainzilber M. Ligand-induced internalization of the p75 neurotrophin receptor: a slow route to the signaling endosome. J Neurosci. 2003;23:3209\u201320.","journal-title":"J Neurosci"},{"key":"2032_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.mcn.2006.06.001","volume":"32","author":"AP Hibbert","year":"2006","unstructured":"Hibbert AP, Kramer BMR, Miller FD, Kaplan DR. The localization, trafficking and retrograde transport of BDNF bound to p75NTR in sympathetic neurons. Mol Cell Neurosci. 2006;32:387\u2013402.","journal-title":"Mol Cell Neurosci"},{"key":"2032_CR36","doi-asserted-by":"crossref","unstructured":"Deinhardt K, Reversi, Berninghausen O, Hopkins, Schiavo. Neurotrophins Redirect p75(NTR) from a Clathrin-Independent to a Clathrin-Dependent Endocytic Pathway Coupled to Axonal Transport. Traffic. 2007;8:1736\u201349. Available from: http:\/\/www.blackwell-synergy.com\/doi\/abs\/10.1111\/j.1600-0854.2007.00645.x.","DOI":"10.1111\/j.1600-0854.2007.00645.x"},{"key":"2032_CR37","doi-asserted-by":"publisher","first-page":"112774","DOI":"10.1016\/j.celrep.2023.112774","volume":"42","author":"J Aow","year":"2023","unstructured":"Aow J, Huang T-R, Goh YT, Sun AX, Thinakaran G, Koo EH. Evidence for a clathrin-independent endocytic pathway for APP internalization in the neuronal somatodendritic compartment. Cell Rep. 2023;42:112774.","journal-title":"Cell Rep"},{"key":"2032_CR38","doi-asserted-by":"crossref","unstructured":"Lee KF, Li E, Huber LJ, Landis SC, Sharpe A, Chao MV, et al. Targeted mutation of the gene encoding the low affinity Ngf Receptor P75 leads to deficits in the peripheral sensory nervous-system. Cell. 1992;69:737\u201349. Available from: http:\/\/links.isiglobalnet2.com\/gateway\/Gateway.cgi?GWVersion=2&SrcAuth=mekentosj&SrcApp=Papers&DestLinkType=FullRecord&DestApp=WOS&KeyUT=A1992HW83800005.","DOI":"10.1016\/0092-8674(92)90286-L"},{"key":"2032_CR39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/glia.24113","volume":"70","author":"Y Ma","year":"2022","unstructured":"Ma Y, Liu H, Ou Z, Qi C, Xing R, Wang S, et al. DHHC5 facilitates oligodendrocyte development by palmitoylating and activating STAT3. Glia. 2022;70:379\u201392.","journal-title":"Glia"},{"key":"2032_CR40","doi-asserted-by":"crossref","unstructured":"Sherman MA, Lesn\u00e9 SE. Detecting a\u03b2*56 oligomers in brain tissues. Methods Mol Biol. 2011;670:45\u201356. Available from: http:\/\/link.springer.com\/10.1007\/978-1-60761-744-0_4.","DOI":"10.1007\/978-1-60761-744-0_4"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02032-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02032-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02032-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:00:31Z","timestamp":1781643631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02032-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2032"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02032-5","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed under the guidelines set by the Institutional Animal Care and Use Committee of Chinese Institute for Brain Research, Beijing (CIBR-IACUC-028).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}